Csl behring

Index
Globenewswire

CSL Joins Accumulus Synergy to Drive Industry Change

Globenewswire

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe